Kinase-driven metabolic signalling as a predictor of response to carboplatin–paclitaxel adjuvant treatment in advanced ovarian cancers

BACKGROUND: The biological mechanisms underlying early- and advanced-stage epithelial ovarian cancers (EOCs) are still poorly understood. This study explored kinase-driven metabolic signalling in early and advanced EOCs, and its role in tumour progression and response to carboplatin–paclitaxel treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sereni, Maria Isabella, Baldelli, Elisa, Gambara, Guido, Ravaggi, Antonella, Hodge, K Alex, Alberts, David S, Guillen-Rodriguez, Jose M, Dong, Ting, Memo, Maurizio, Odicino, Franco, Angioli, Roberto, Liotta, Lance A, Pecorelli, Sergio L, Petricoin, Emanuel F, Pierobon, Mariaelena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558684/
https://www.ncbi.nlm.nih.gov/pubmed/28664915
http://dx.doi.org/10.1038/bjc.2017.195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558684/
https://www.ncbi.nlm.nih.gov/pubmed/28664915
http://dx.doi.org/10.1038/bjc.2017.195

Ejemplares similares